Literature DB >> 32358840

High-level induction of fetal haemoglobin by pomalidomide in β-thalassaemia/HbE erythroid progenitor cells.

Pinyaphat Khamphikham1,2, Tiwaporn Nualkaew1, Phitchapa Pongpaksupasin1,3, Woratree Kaewsakulthong1,3, Duantida Songdej4, Kittiphong Paiboonsukwong1, James D Engel5, Suradej Hongeng4, Suthat Fucharoen1, Orapan Sripichai6, Natee Jearawiriyapaisarn1.   

Abstract

Entities:  

Keywords:  decitabine; fetal haemoglobin induction; hydroxyurea; pomalidomide; β-thalassaemia/HbE

Year:  2020        PMID： 32358840     DOI： 10.1111/bjh.16670

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  A hypothesis about the role of fetal hemoglobin in COVID-19.

Authors:  Ehsan Sotoudeh; Houman Sotoudeh
Journal:  Med Hypotheses       Date:  2020-06-12       Impact factor: 1.538

Review 2.  Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis.

Authors:  Yanfei Lu; Zhenbin Wei; Gaohui Yang; Yongrong Lai; Rongrong Liu
Journal:  Front Pharmacol       Date:  2022-01-11       Impact factor: 5.810

Review 3.  Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective.

Authors:  Rayan Bou-Fakhredin; Lucia De Franceschi; Irene Motta; Maria Domenica Cappellini; Ali T Taher
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.